Christopher S John

age ~31

from Philadelphia, PA

Get Report

Also known as:

Christopher Null

Connected to:

Christopher John Phones & Addresses

Philadelphia, PA
112 Heritage Rd, Maple Shade, NJ 08052
Willingboro, NJ
Far Rockaway, NY
Rich Creek, VA

Resumes

Christopher John Powhatan, VA

view source

Work:

Firebirds Wood-Fired Grill

2008 to 2012
Guest Assistant

Education:

Virginia Polytechnic Institute and State University
2010 to 2014
Bachelor of Science in Biological Sciences Virginia Tech
Blacksburg, VA
2010 to 2014

Skills:

Practical Lab techniques, Computer skills

Name / Title

Company / Classification

Phones & Addresses

Christopher John
Owner / President

WOLVERINE WAREHOUSING & DISTRIBUTION LIMITED
Transportation Services

3950 Malden Road, Windsor, ON N9C 2G4
5199671106

Betty W Murchison
Executive

Murchison-John Realty
Real Estate Agents and Managers

306 W. 38Th Street Suite 1506, New York, NY 10018

Christopher John
Executive

Murchison-John Realty

306 W 38 St SUITE 1506, New York, NY 10018
2025265190

Christopher John

TINT N TRIM Window Tinting

4614 Louise St Claire Dr, Doylestown, PA 18902
2154919041

Christopher John
Director

BLACKSTAR SYSTEMS INC
It Consultant Svcs

78 E 54 St, Brooklyn, NY 11203

Us Patents

Pharmaceutical Compositions Of Combinations Of Dipeptidyl Peptidase-4 Inhibitors With Pioglitazone
view source
US Patent:

20120059011, Mar 8, 2012
Filed:

Jun 4, 2010
Appl. No.:

13/319718
Inventors:

Nicholas Birringer - Philadelphia PA, US
Christopher T. John - Perkiomenville PA, US
Adam Procopio - Cinnaminson NJ, US
Bhagwant Rege - Collegeville PA, US
Lawrence A. Rosen - Wayne PA, US
Sutthilug Sotthivirat - Lansdale PA, US
Wei Xu - North Wales PA, US
International Classification:

A61K 31/4439
A61K 31/513
A61P 3/10
A61K 31/4985
US Classification:

514249, 514342, 514274
Abstract:

This invention relates to pharmaceutical compositions comprising fixed-dose combinations of a dipeptidyl peptidase-4 inhibitor and pioglitazone, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes with such pharmaceutical compositions.

Pharmaceutical Compositions Of Combinations Of Dipeptidyl Peptidase-4 Inhibitors With Pioglitazone
view source
US Patent:

20120201885, Aug 9, 2012
Filed:

Oct 12, 2010
Appl. No.:

13/501252
Inventors:

Nicholas Birringer - Philadelphia PA, US
Christopher T. John - Perkiomenville PA, US
Zhen Liu - Chalfont PA, US
Adam Procopio - Cinnaminson NJ, US
Bhagwant Rege - Rockville MD, US
International Classification:

A61K 9/20
A61K 31/675
A61P 3/10
A61K 31/513
A61K 31/4439
A61K 9/28
A61K 31/4985
US Classification:

424465, 424464, 424474, 514 81, 514249, 514274, 514342
Abstract:

This invention relates to a bilayer pharmaceutical compositions comprising fixed-dose combinations of a dipeptidyl peptidase-4 inhibitor and pioglitazone, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes with such pharmaceutical compositions.

Lawyers & Attorneys

Christopher Tod St. John, New York NY - Lawyer

view source

Address:

Fragomen, Del Rey, Bernsen & Loewy, LLP
515 Madison Avenue Lbby, New York, NY 10022
2128917583 (Office)

Licenses:

New York - Currently registered 2003

Education:

St Mary's University of San Antonio School of Law
Degree - JD - Juris Doctor - Law
Graduated - 2002
University of Texas System, Austin
Degree - BA - Bachelor of Arts
Graduated - 1998

Specialties:

Immigration - 40%
Antitrust / Trade Law - 20%
Intellectual Property - 20%
Mergers / Acquisitions - 20%